Esperion Therapeutics PE Ratio 2012-2025 | ESPR

Current and historical p/e ratio for Esperion Therapeutics (ESPR) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Esperion Therapeutics PE ratio as of January 23, 2026 is 0.00.
Esperion Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-01-23 3.14 0.00
2025-09-30 2.65 $-0.50 0.00
2025-06-30 0.98 $-0.49 0.00
2025-03-31 1.44 $-0.80 0.00
2024-12-31 2.20 $-0.25 0.00
2024-09-30 1.65 $-0.64 0.00
2024-06-30 2.22 $-0.86 0.00
2024-03-31 2.68 $-0.99 0.00
2023-12-31 2.99 $-2.12 0.00
2023-09-30 0.98 $-2.38 0.00
2023-06-30 1.39 $-2.82 0.00
2023-03-31 1.59 $-3.41 0.00
2022-12-31 6.23 $-3.55 0.00
2022-09-30 6.70 $-4.56 0.00
2022-06-30 6.36 $-6.37 0.00
2022-03-31 4.64 $-6.99 0.00
2021-12-31 5.00 $-9.56 0.00
2021-09-30 12.05 $-11.68 0.00
2021-06-30 21.15 $-12.13 0.00
2021-03-31 28.05 $-6.14 0.00
2020-12-31 26.00 $-5.48 0.00
2020-09-30 37.17 $-3.85 0.00
2020-06-30 51.31 $-3.30 0.00
2020-03-31 31.53 $-9.63 0.00
2019-12-31 59.63 $-3.72 0.00
2019-09-30 36.66 $-3.70 0.00
2019-06-30 46.52 $-3.04 0.00
2019-03-31 40.15 $-2.74 0.00
2018-12-31 46.00 $-7.54 0.00
2018-09-30 44.37 $-6.74 0.00
2018-06-30 39.19 $-6.74 0.00
2018-03-31 72.33 $-6.95 0.00
2017-12-31 65.84 $-7.02 0.00
2017-09-30 50.12 $-6.87 0.00
2017-06-30 46.28 $-5.78 0.00
2017-03-31 35.31 $-4.48 0.00
2016-12-31 12.52 $-3.33 0.00
2016-09-30 13.85 $-2.62 0.00
2016-06-30 9.88 $-2.42 0.00
2016-03-31 16.91 $-2.35 0.00
2015-12-31 22.26 $-2.26 0.00
2015-09-30 23.59 $-2.17 0.00
2015-06-30 81.76 $-2.24 0.00
2015-03-31 92.60 $-2.29 0.00
2014-12-31 40.44 $-2.24 0.00
2014-09-30 24.46 $-2.38 0.00
2014-06-30 15.84 $-2.08 0.00
2014-03-31 15.12 $-21.30 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.758B $0.332B
Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.081B 33.08
Zoetis (ZTS) United States $54.822B 19.62
Takeda Pharmaceutical (TAK) Japan $50.721B 10.35
Daiichi Sankyo, - (DSNKY) Japan $37.925B 18.89
BeOne Medicines - (ONC) Switzerland $37.155B 196.98
Sandoz Group AG (SDZNY) Switzerland $34.654B 0.00
United Therapeutics (UTHR) United States $20.325B 17.89
Merck (MKKGY) Germany $19.522B 12.04
Shionogi (SGIOY) Japan $16.214B 14.89
Neurocrine Biosciences (NBIX) United States $13.697B 32.86
Summit Therapeutics (SMMT) United States $13.395B 0.00
IPSEN (IPSEY) France $13.337B 0.00
Ionis Pharmaceuticals (IONS) United States $13.248B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.311B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.236B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.967B 21.19
Grifols, S.A (GRFS) Spain $6.264B 0.00
Stevanato Group S.p.A (STVN) Italy $5.802B 32.47
Crinetics Pharmaceuticals (CRNX) United States $5.214B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.547B 0.00
Corcept Therapeutics (CORT) United States $4.344B 46.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.269B 20.27
Indivior (INDV) United States $4.193B 17.11
NewAmsterdam Pharma (NAMS) Netherlands $3.947B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.313B 0.00
Hypermarcas (HYPMY) Brazil $3.192B 21.91
Catalyst Pharmaceuticals (CPRX) United States $3.005B 9.59
Dyne Therapeutics (DYN) United States $2.582B 0.00
Ocular Therapeutix (OCUL) United States $2.369B 0.00
Soleno Therapeutics (SLNO) United States $2.350B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.103B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.959B 23.22
Ardelyx (ARDX) United States $1.927B 0.00
Guardian Pharmacy Services (GRDN) United States $1.924B 37.06
Amylyx Pharmaceuticals (AMLX) United States $1.782B 0.00
Oruka Therapeutics (ORKA) United States $1.720B 0.00
Harrow (HROW) United States $1.679B 103.00
Enliven Therapeutics (ELVN) United States $1.604B 0.00
Collegium Pharmaceutical (COLL) United States $1.489B 7.37
BioCryst Pharmaceuticals (BCRX) United States $1.422B 84.38
Relay Therapeutics (RLAY) United States $1.317B 0.00
Savara (SVRA) United States $1.314B 0.00
Evotec AG (EVO) Germany $1.275B 0.00
Xeris Biopharma Holdings (XERS) United States $1.263B 0.00
Aktis Oncology (AKTS) United States $1.135B 0.00
Theravance Biopharma (TBPH) United States $1.051B 44.13
ARS Pharmaceuticals (SPRY) United States $1.045B 0.00
Cronos Group (CRON) Canada $1.023B 0.00
Xencor (XNCR) United States $0.936B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.877B 20.73
KalVista Pharmaceuticals (KALV) United States $0.836B 0.00
Nektar Therapeutics (NKTR) United States $0.743B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.688B 6.15
Bioventus (BVS) United States $0.675B 13.81
ProKidney (PROK) United States $0.656B 0.00
Altimmune (ALT) United States $0.561B 0.00
Lexeo Therapeutics (LXEO) United States $0.561B 0.00
Lyell Immunopharma (LYEL) United States $0.549B 0.00
Zevra Therapeutics (ZVRA) United States $0.511B 0.00
Organogenesis (ORGO) United States $0.508B 0.00
Elite Pharmaceuticals (ELTP) United States $0.494B 0.00
Aclaris Therapeutics (ACRS) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.482B 6.60
4D Molecular Therapeutics (FDMT) United States $0.462B 0.00
Nature's Sunshine Products (NATR) United States $0.429B 25.56
USANA Health Sciences (USNA) United States $0.412B 11.48
Aquestive Therapeutics (AQST) United States $0.397B 0.00
Cybin (HELP) Canada $0.385B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Aldeyra Therapeutics (ALDX) United States $0.314B 0.00
Protara Therapeutics (TARA) United States $0.305B 0.00
Avalo Therapeutics (AVTX) United States $0.301B 0.00
OmniAb (OABI) United States $0.298B 0.00
Achieve Life Sciences (ACHV) Canada $0.294B 0.00
Relmada Therapeutics (RLMD) United States $0.290B 0.00
Larimar Therapeutics (LRMR) United States $0.286B 0.00
Fractyl Health (GUTS) United States $0.284B 0.00
Profound Medical (PROF) Canada $0.281B 0.00
Silence Therapeutics (SLN) United Kingdom $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.266B 0.00
Journey Medical (DERM) United States $0.251B 0.00
Enlivex Therapeutics (ENLV) Israel $0.249B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.231B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
MediWound (MDWD) Israel $0.225B 0.00
Century Therapeutics (IPSC) United States $0.202B 0.00
AleAnna (ANNA) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Surrozen (SRZN) United States $0.171B 0.00
Minerva Neurosciences (NERV) United States $0.169B 0.00
Context Therapeutics (CNTX) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.156B 0.00
Unicycive Therapeutics (UNCY) United States $0.153B 0.00
Prelude Therapeutics (PRLD) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.135B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Incannex Healthcare (IXHL) Australia $0.124B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.124B 0.00
Karyopharm Therapeutics (KPTI) United States $0.122B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.106B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Korro Bio (KRRO) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.096B 40.76
Gain Therapeutics (GANX) United States $0.080B 0.00
PolyPid (PYPD) Israel $0.076B 0.00
Assertio Holdings (ASRT) United States $0.075B 0.00
NRx Pharmaceuticals (NRXP) United States $0.069B 0.00
Dominari Holdings (DOMH) United States $0.068B 0.00
Metagenomi Therapeutics (MGX) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
Arch Biopartners (ACHFF) Canada $0.062B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.060B 50.50
Lipocine (LPCN) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Lite Strategy (LITS) United States $0.049B 0.00
Talphera (TLPH) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Wellgistics Health (WGRX) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
TherapeuticsMD (TXMD) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Klotho Neurosciences (KLTO) United States $0.025B 0.00
Liminatus Pharma (LIMN) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Traws Pharma (TRAW) United States $0.020B 0.03
Inotiv (NOTV) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Vyome Holdings (HIND) United States $0.016B 0.00
Tempest Therapeutics (TPST) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
BioVie (BIVI) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00